Immunotherapy after surgery may improve survival in people with high-risk bladder cancer: NEJM Dr. Kamal Kant Kohli18 Sept 2024 2:30 AM ISTResults from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk,...
European Commission approves Janssen-Cilag Balversa for adult patients with metastatic urothelial carcinoma Ruchika Sharma25 Aug 2024 10:00 AM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the European Commission (EC) has approved...
FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer Dr. Kamal Kant Kohli30 April 2024 7:00 AM ISTThe U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the brand name Anktiva, to be...
Urine test halves painful procedures in bladder cancer follow up, new trial shows Dr. Kamal Kant Kohli12 April 2024 6:00 AM ISTA simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. ...
Blood test can predict risk of relapse in advanced bladder cancer patients following surgery, suggests study Dr. Kamal Kant Kohli6 April 2024 7:00 AM ISTTesting for tumour DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following surgery, new research...
USFDA approves Opdivo in combo with Cisplatin and Gemcitabine for first-line treatment of adult patients with metastatic Urothelial Carcinoma: Bristol Myers Squibb Ruchika Sharma9 March 2024 1:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab), in combination...
New test could predict immunotherapy responders for broader range of cancers than current tools Dr. Kamal Kant Kohli15 Feb 2024 2:00 AM ISTA newly identified genetic marker could potentially predict which patients are likely to respond to immunotherapy in cancer types that have lacked...
JnJ Balversa gets full USFDA nod to treat locally advanced or metastatic Bladder Cancer with Select Genetic Alterations Ruchika Sharma21 Jan 2024 4:30 PM ISTRaritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application...
Medical Bulletin 17/January/2024 Anshika Mishra17 Jan 2024 3:00 PM ISTHere are the top medical news stories of the day:Bladder tumors reduced by 90% using nanorobotsBladder cancer has one of the highest incidence rates...
Bladder tumors reduced by 90% using nanorobots Anshika Mishra17 Jan 2024 9:00 AM ISTBladder cancer has one of the highest incidence rates in the world and ranks as the fourth most common tumour in men. Despite its relatively low...
Urease-powered nanorobots reduced bladder tumours by 90 per cent Dr. Kamal Kant Kohli16 Jan 2024 5:28 PM ISTSpain: A recent study published in the prestigious journal Nature Nanotechnology reveals how a research team successfully reduced the size of bladder...
Merck bags USFDA nod for Keytruda, Padcev combo for urothelial cancer Ruchika Sharma18 Dec 2023 1:45 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA,...
